{"id":247,"date":"2020-12-23T15:03:13","date_gmt":"2020-12-23T22:03:13","guid":{"rendered":"https:\/\/neurotucson.fm1.dev\/neurology\/neurosurgery-clinical-trials\/"},"modified":"2021-03-31T15:28:25","modified_gmt":"2021-03-31T21:28:25","slug":"neurosurgery-clinical-trials","status":"publish","type":"page","link":"https:\/\/neurotucson.com\/neurology\/neurosurgery-clinical-trials\/","title":{"rendered":"Neurosurgery Clinical Trials"},"content":{"rendered":"\n
If you are interested in learning more about one of our ongoing clinical trials, please feel free to call our Clinical Research Program at 520-320-2147<\/a>.<\/p>\n\n\n\n This study is comparing the effects of an investigational drug versus placebo on participants and their memory problems.<\/p>\n\n\n\n The PASSAGE study is a long-term study monitoring safety in patients newly started on pharmaceutical therapy for MS.<\/p>\n\n\n\n This feasibility study will assess the effects of the Nativis Voyager therapy in patients newly diagnosed with GBM (Glioblastoma Multiforme). The study will enroll and treat up to 11 subjects and will be combined with standard of care radiotherapy and temozolomide.<\/p>\n\n\n\n This study will help us learn more about a newly discovered vaccine drug that is being tested in people with recurrent or progressive glioblastoma, who have already received treatment.<\/p>\n\n\n\n This study is to evaluate the safety, efficacy and clinical activity of BGB-290 in combination with radiation therapy (RT) and\/or temozolomide (TMZ) in subjects with newly diagnosed or recurrent\/refractory glioblastoma.<\/p>\n\n\n\nAlzheimer\u2019s Disease Clinical Trial \u2013 Now Enrolling<\/h2>\n\n\n\n
Early Alzheimer\u2019s Disease: Genentech GRADUATE Study<\/a><\/h3>\n\n\n\n
Multiple Sclerosis Clinical Trial \u2013 Now Enrolling<\/h2>\n\n\n\n
Multiple Sclerosis Study: Novartis PASSAGE Study<\/a><\/h3>\n\n\n\n
Glioblastoma Clinical Trial \u2013 Now Enrolling<\/h2>\n\n\n\n
Glioblastoma Study: Nativis VOYAGER<\/a><\/h3>\n\n\n\n
Glioblastoma Clinical Trial \u2013 Now Enrolling<\/h2>\n\n\n\n
Recurrent Glioblastoma: Boston Biomedical Wizard Study<\/a><\/h3>\n\n\n\n
Glioblastoma Clinical Trial \u2013 Now Enrolling<\/h2>\n\n\n\n
Recurrent and Newly Diagnosed Glioblastoma: BeiGene BGB-290 Study<\/a><\/h3>\n\n\n\n